Severity‐Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19‐Targeted CAR T‐Cell Therapy

ABSTRACT:

SUBMITTER: Vilaseca A 

PROVIDER: S-EPMC12325479 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature